Evidence map›Paper›PMID 40161310›Full record

ArticleCurrent research in food science2025

Hawthorn leaf and its extract alleviate high-fat diet-induced obesity and modulate gut microbiome in mice.

Ziqi Liu, Tianrui Gao, Haoyu Chang, Yuqing Xu, Letao Wang, Xiangyi Wang, Jiayin Lang, Yingxing Yu, Ying Xiao, Ye Peng

Abstract read
In one paragraph

Article in Current research in food science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ziqi LiuFaculty of Chinese Medicine, Macau University of Science and Technology, Taipa, 999078, China.
Tianrui GaoFaculty of Medicine, Macau University of Science and Technology, Taipa, 999078, China.
Haoyu ChangFaculty of Chinese Medicine, Macau University of Science and Technology, Taipa, 999078, China.
Yuqing XuFaculty of Medicine, Macau University of Science and Technology, Taipa, 999078, China.
Letao WangFaculty of Medicine, Macau University of Science and Technology, Taipa, 999078, China.
Xiangyi WangFaculty of Medicine, Macau University of Science and Technology, Taipa, 999078, China.
Jiayin LangFaculty of Medicine, Macau University of Science and Technology, Taipa, 999078, China.
Yingxing YuGuangdong-Hong Kong-Macao Joint Laboratory for Contaminants Exposure and Health, Guangdong Key Laboratory of Environmental Catalysis and Health Risk Control, Institute of Environmental Health and Pollution Control, Guangdong University of Technology, Guangzhou, 510006, China.
Ying XiaoFaculty of Medicine, Macau University of Science and Technology, Taipa, 999078, China.
Ye PengFaculty of Medicine, Macau University of Science and Technology, Taipa, 999078, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity has emerged as a global health issue with its prevalence continuously increasing and being associated with multiple comorbidities. Although existing medications are effective, they often come with significant side effects, making dietary therapy an advantageous alternative. Hawthorn leaves and their active component, vitexin, have shown potential in regulating lipid metabolism and improving gut microbiota imbalance. This study utilized a high-fat diet-induced obese mouse model, administering different doses of hawthorn leaves and vitexin for 13 weeks, and employed 16S rRNA sequencing and metabolomics to analyze the composition of gut microbiota and metabolites. The results demonstrated that hawthorn leaves and vitexin significantly slowed body weight gain, improved glucose tolerance, regulated blood lipid levels, and downregulated the expression of obesity-related gene in mice (

Indexed as

Gut microbiotaHawthorn leavesMetabolic regulationObesityVitexin

Identifiers

PMID40161310
PMCPMC11951210

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.